This observational registry will characterize contemporary stroke prevention in Canadian
adults with atrial fibrillation, and provide clarity in understanding physician preferences
for the various oral anticoagulants available in the Canadian marketplace. This study will
determine the patient profiles of those selected for the various therapies available in
Canada and provide an understanding of the factors involved in drug selection and management.